Security Snapshot

IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX) Institutional Ownership

CUSIP: 4525EP101

13F Institutional Holders and Ownership History from Q2 2019 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

74

Shares (Excl. Options)

63,951,636

Price

$1.11

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+14,285,377
Value change
+$17,381,778
Number of holders
74
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
130,556,701
SEC-reported price per share
$0.88
Insider filing price
$0.88
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • IMUX - IMMUNIC, INC. - Common Stock, $0.0001 par value is tracked under CUSIP 4525EP101.
  • 74 institutions reported positions in Q1 2026.
  • 18 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 58 to 74 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $25,965,609 to $70,999,597.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 74 institutions filings for Q1 2026.

Open SEC evidence

Security key

4525EP101

Latest holder period

Q1 2026

13F holders

74

13D/G owners

18

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
18
Security
IMUX
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Vivo Opportunity Fund Holdings, L.P. 10% $17,767,413 29,126,906 Vivo Opportunity Fund Holdings, L.P. 17 Feb 2026
Avidity Partners Management LP 9.9% +102% $15,493,835 +$10,277,489 13,958,410 +197% Avidity Partners Management LP 17 Feb 2026
BIOTECHNOLOGY VALUE FUND L P 10% 0% $8,314,667 +$2,345,708 13,630,601 +39% BVF PARTNERS L P/IL 12 Feb 2026
Commodore Capital LP 9.9% $8,143,574 13,350,121 Commodore Capital LP 17 Feb 2026
JANUS HENDERSON GROUP PLC 10% +233% $8,531,675 +$6,622,427 12,016,444 +347% JANUS HENDERSON GROUP PLC 28 Nov 2025
Deep Track Capital, LP 8.7% $9,964,980 11,454,000 Deep Track Capital, LP 17 Feb 2026
Trails Edge Capital Partners, LP 8.7% $6,986,940 11,454,000 Trails Edge Capital Partners, LP 17 Feb 2026
Adage Capital Management, L.P. 10% +422% $8,697,850 +$7,537,012 10,479,337 +649% Adage Capital Management, L.P. 30 Jun 2025
Nantahala Capital Management, LLC 8.2% -18% $7,057,316 -$174,188 10,378,406 -2.4% Nantahala Capital Management, LLC 31 Dec 2025
Aberdeen Group plc 6.8% -19% $4,399,791 8,243,941 0% Aberdeen Group plc 31 Dec 2025
Soleus Capital Master Fund, L.P. 5.5% $4,143,120 6,792,000 Soleus Capital Master Fund, L.P. 17 Feb 2026
Alyeska Investment Group, L.P. 4.8% -23% $7,345,120 -$1,354,880 6,332,000 -16% Alyeska Investment Group, L.P. 31 Mar 2026
VANGUARD GROUP INC 4.4% $4,473,090 3,923,763 The Vanguard Group 31 Dec 2024
Soleus Private Equity Fund III, L.P. 1.6% $1,392,934 1,580,007 Soleus Capital Management, L.P. 30 Sep 2025
RTW INVESTMENTS, LP 1.1% $1,170,509 1,026,762 RTW Investments, LP 31 Mar 2025
INTEGRATED CORE STRATEGIES (US) LLC 5.7% $920,600 793,621 Millennium Management LLC 29 Apr 2026
683 Capital Management, LLC 3.4% -42% $550,072 -$8,149,928 474,200 -94% 683 CAPITAL MANAGEMENT, LLC 31 Mar 2026
ARMISTICE CAPITAL, LLC 5% -50% $328,030 -$49,773 372,085 -13% Armistice Capital, LLC 30 Sep 2025

As of 31 Mar 2026, 74 institutional investors reported holding 63,951,636 shares of IMMUNIC, INC. - Common Stock, $0.0001 par value (IMUX). This represents 49% of the company’s total 130,556,701 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
47%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Aberdeen Group plc 6.3% 8,243,941 0% 0.01% $9,150,775
BVF INC/IL 5.9% 7,652,972 0% 0.27% $8,494,799
Avidity Partners Management LP 5.1% 6,699,411 +43% 1.5% $7,436,346
VANGUARD CAPITAL MANAGEMENT LLC 3.9% 5,138,316 0% 0% $5,703,531
Soleus Capital Management, L.P. 3.4% 4,500,000 0.2% $4,995,000
Laurion Capital Management LP 3% 3,882,162 0% 0.4% $4,309,200
MILLENNIUM MANAGEMENT LLC 2.9% 3,779,922 +11% 0% $4,195,713
MORGAN STANLEY 2.5% 3,288,540 +57% 0% $3,650,280
Nantahala Capital Management, LLC 1.9% 2,506,491 -43% 0.17% $2,782,205
683 Capital Management, LLC 1.9% 2,450,000 0.25% $2,719,500
Propel Bio Management, LLC 1.8% 2,344,779 1.7% $2,620,262
GEODE CAPITAL MANAGEMENT, LLC 1.2% 1,525,769 +30% 0% $1,694,330
ADAGE CAPITAL PARTNERS GP, L.L.C. 1.1% 1,398,600 0% 0% $1,552,446
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.79% 1,028,256 +208% 0% $1,141,364
Woodline Partners LP 0.74% 967,152 0% $1,073,539
BlackRock, Inc. 0.74% 964,230 +34% 0% $1,070,295
RENAISSANCE TECHNOLOGIES LLC 0.7% 919,164 0% $1,020,272
VANGUARD FIDUCIARY TRUST CO 0.57% 740,542 0% 0% $822,002
Ikarian Capital, LLC 0.52% 674,662 0% 0.11% $748,876
JANE STREET GROUP, LLC 0.5% 659,153 +130% 0% $731,659
STATE STREET CORP 0.43% 565,645 +70% 0% $627,866
UBS Group AG 0.4% 522,797 -2.7% 0% $580,305
HRT FINANCIAL LP 0.38% 493,393 0% $547,000
Simplify Asset Management Inc. 0.34% 438,932 0.01% $487,215
NORTHERN TRUST CORP 0.2% 263,328 +19% 0% $292,294

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
28
Latest
Q1 2026
Rows shown
1-25 of 28
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 63,951,636 $70,999,597 +$17,381,778 $1.11 74
2025 Q4 48,654,047 $25,965,609 +$3,658,356 $0.53 58
2025 Q3 42,691,219 $37,637,800 -$6,010,022 $0.88 61
2025 Q2 50,178,419 $35,007,422 +$6,044,822 $0.70 55
2025 Q1 40,453,267 $44,092,350 -$10,908,092 $1.09 63
2024 Q4 51,078,929 $51,080,793 -$5,070,929 $1.00 65
2024 Q3 55,990,706 $92,402,857 +$4,082,986 $1.65 61
2024 Q2 55,825,550 $62,078,863 -$1,856,872 $1.11 57
2024 Q1 57,356,707 $75,746,429 +$55,567,381 $1.32 60
2023 Q4 15,140,220 $22,708,217 -$4,865,374 $1.50 49
2023 Q3 18,373,010 $27,006,486 -$3,552,617 $1.47 53
2023 Q2 20,191,368 $50,673,312 -$8,732,751 $2.51 62
2023 Q1 24,789,103 $36,932,167 +$1,129,629 $1.49 57
2022 Q4 24,354,230 $34,040,740 +$5,454,473 $1.40 59
2022 Q3 17,440,399 $55,106,794 -$3,092,179 $3.16 62
2022 Q2 18,260,665 $63,350,669 -$15,186,048 $3.47 65
2022 Q1 17,606,263 $198,949,802 +$44,387,028 $11.30 78
2021 Q4 13,709,674 $131,117,717 +$7,603,275 $9.57 66
2021 Q3 12,872,467 $113,976,993 +$30,193,655 $8.85 66
2021 Q2 9,434,902 $115,673,222 -$1,395,354 $12.26 56
2021 Q1 9,300,714 $148,252,917 -$6,173,953 $15.94 60
2020 Q4 9,727,941 $148,744,642 +$11,593,540 $15.29 66
2020 Q3 8,546,270 $158,699,665 +$86,090,223 $18.57 64
2020 Q2 4,206,160 $51,019,563 +$24,949,305 $12.12 47
2020 Q1 2,155,699 $13,039,030 +$104,044 $6.01 15
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .